Omeros Corp (OMER)
10.91
+3.18
(+41.14%)
USD |
NASDAQ |
Nov 22, 16:00
10.91
0.00 (0.00%)
After-Hours: 20:00
Omeros Enterprise Value: 698.53M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 698.53M |
| November 21, 2024 | 514.25M |
| November 20, 2024 | 415.74M |
| November 19, 2024 | 415.74M |
| November 18, 2024 | 409.36M |
| November 15, 2024 | 457.46M |
| November 14, 2024 | 469.05M |
| November 13, 2024 | 309.11M |
| November 12, 2024 | 313.17M |
| November 11, 2024 | 314.91M |
| November 08, 2024 | 321.86M |
| November 07, 2024 | 327.08M |
| November 06, 2024 | 329.97M |
| November 05, 2024 | 321.28M |
| November 04, 2024 | 312.59M |
| November 01, 2024 | 302.74M |
| October 31, 2024 | 300.42M |
| October 30, 2024 | 310.85M |
| October 29, 2024 | 314.91M |
| October 28, 2024 | 313.17M |
| October 25, 2024 | 309.11M |
| October 24, 2024 | 312.01M |
| October 23, 2024 | 305.63M |
| October 22, 2024 | 312.01M |
| October 21, 2024 | 303.90M |
| Date | Value |
|---|---|
| October 18, 2024 | 306.79M |
| October 17, 2024 | 306.21M |
| October 16, 2024 | 306.21M |
| October 15, 2024 | 304.48M |
| October 14, 2024 | 296.36M |
| October 11, 2024 | 293.47M |
| October 10, 2024 | 287.09M |
| October 09, 2024 | 288.25M |
| October 08, 2024 | 291.73M |
| October 07, 2024 | 289.41M |
| October 04, 2024 | 284.77M |
| October 03, 2024 | 285.93M |
| October 02, 2024 | 299.26M |
| October 01, 2024 | 287.67M |
| September 30, 2024 | 296.36M |
| September 27, 2024 | 259.63M |
| September 26, 2024 | 259.63M |
| September 25, 2024 | 253.26M |
| September 24, 2024 | 258.47M |
| September 23, 2024 | 250.94M |
| September 20, 2024 | 259.63M |
| September 19, 2024 | 266.01M |
| September 18, 2024 | 260.21M |
| September 17, 2024 | 264.27M |
| September 16, 2024 | 258.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
74.32M
Minimum
Oct 27 2023
1.552B
Maximum
Feb 19 2021
595.64M
Average
474.39M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.314M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.23M |
| Total Expenses (Quarterly) | 35.41M |
| EPS Diluted (Quarterly) | -0.56 |
| Earnings Yield | -21.17% |
| Normalized Earnings Yield | -20.25 |